![](/img/cover-not-exists.png)
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial
Maher, Toby M, Corte, Tamera J, Fischer, Aryeh, Kreuter, Michael, Lederer, David J, Molina-Molina, Maria, Axmann, Judit, Kirchgaessler, Klaus-Uwe, Cottin, VincentVolume:
5
Language:
english
Journal:
BMJ Open Respiratory Research
DOI:
10.1136/bmjresp-2018-000289
Date:
September, 2018
File:
PDF, 1.96 MB
english, 2018